Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BESTOW: Tegoprubart vs Tacrolimus in Kidney Transplantation
NCT05983770Phase 2Completed
- Sponsor
- Eledon Pharmaceuticals, Inc.
- Start
- Aug 2023
- Primary completion
- Sep 2025
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of tegoprubart in kidney transplant rejection, sponsored by Eledon Pharmaceuticals, Inc.. Started Aug 2023; status: completed.
02
Drugs
tegoprubart
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT05983770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05983770.